Sean Hashemi, MD
Otolaryngology · Chico
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Enloe Medical Center · 330 clinicians in this group
Hospitals listed: Enloe Health. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Hashemi’s office at (530) 342-2411 to ask if they take your plan before you enroll.
California Medical Board record
Licence A161622 · Current
Licensed to practise in California · since 2019 · expires 2027-03-31 · George Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Enloe HealthChico, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Enloe Medical CenterPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 6.9 (5.5 to 8.6) · 730 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.185, Oct 2024 – Sep 2025
See every measure and the patient survey for Enloe Health
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.9 (5.5 to 8.6) · 730 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.185 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.79 (0.96 to 2.62) · 2,849 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.74 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 203.04 (164.55 to 241.54) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 117 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.8 · 377 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 377 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 1,088 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 1,160 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 375 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 4,102 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.05 to 0.39) · 14,875 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.17 (0 to 0.34) · 15,303 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.75 (2.11 to 5.39) · 3,517 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.14 (0.71 to 3.56) · 1,262 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.89 (1.62 to 4.17) · 3,062 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.91 (1.48 to 12.34) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.66 to 7.91) · 1,219 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.04 (0.64 to 3.43) · 643 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.71 (0.24 to 1.18) · 11,884 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 150 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.739 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.481 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.381 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.344 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 328 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 1,020 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.9 · 400 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 9.3 · 1,292 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 13.3 · 1,204 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 1,055 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.4 (10.4 to 14.7) · 730 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 102 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 90 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 304 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.9 (12.1 to 18.1) · 3,626 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 1,340 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,476 patients answered, 21% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 57% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 40% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$87,008
Medicare paid this office $87,008 for 410 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 190 | $16,915 | $66 |
| New patient visit (45+ min) | 138 | $11,487 | $83 |
| Diagnostic exam of voice box using a flexible endoscope | 90 | $5,017 | $47 |
| Short return visit (20+ min) | 57 | $3,270 | $48 |
| Preparation of skin graft site of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 100.0 sq cm or 1% body area for infants and children, or less | 15 | $3,019 | $201 |
See all 10 services
| Return visit (30+ min) | 190 | $16,915 | $66 |
| New patient visit (45+ min) | 138 | $11,487 | $83 |
| Diagnostic exam of voice box using a flexible endoscope | 90 | $5,017 | $47 |
| Short return visit (20+ min) | 57 | $3,270 | $48 |
| Preparation of skin graft site of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 100.0 sq cm or 1% body area for infants and children, or less | 15 | $3,019 | $201 |
| Removal of impacted ear wax | 72 | $1,721 | $20 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,430 | $102 |
| New patient visit (30+ min) | 17 | $1,027 | $60 |
| Diagnostic exam of nasal passages using an endoscope | 19 | $950 | $43 |
| Short return visit | 13 | $259 | $20 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 13 | More than 67% of doctors who do this |
| Skin biopsy | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Who their Medicare patients are
410 Original Medicare patients in 2024. Average age 74 · Under 65 10% · 85 and older 15% · Women 55% · Also on Medicaid 26% · Health risk score 1.32. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 74% · Diabetes 27% · Depression 22% · Coronary heart disease 21% · COPD 21% · Chronic kidney disease 20% · Atrial fibrillation 18% · Cancer 16% · Heart failure 15% · Stroke 10% · Dementia 6%.
The office billed $281,409, Medicare allowed $119,018 and paid $87,008; for 931 services of 78 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 410 | 931 | 74 | 1.32 | $281,409 | $87,008 |
| 2023 | 455 | 1,144 | 74 | 1.24 | $350,174 | $112,864 |
| 2022 | 699 | 2,008 | 73 | 1.21 | $573,208 | $182,489 |
| 2021 | 694 | 1,886 | 73 | 1.17 | $476,278 | $160,719 |
| 2020 | 172 | 509 | 73 | 1.12 | $111,514 | $37,507 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Return visit (30+ min) | 196 | $20,310 | $73 |
| New patient visit (45+ min) | 208 | $19,264 | $93 |
| Diagnostic exam of voice box using a flexible endoscope | 112 | $6,675 | $53 |
| Preparation of skin graft site of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 100.0 sq cm or 1% body area for infants and children, or less | 15 | $3,348 | $209 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 11 | $3,262 | $130 |
| Short return visit (20+ min) | 39 | $2,506 | $46 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,321 | $129 |
| Removal of impacted ear wax | 79 | $2,207 | $21 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,475 | $105 |
| Diagnostic exam of nasal passages using an endoscope | 22 | $1,434 | $49 |
| New patient visit (30+ min) | 14 | $853 | $61 |
| Short return visit | 18 | $632 | $27 |
2022: 15 services
| New patient visit (45+ min) | 402 | $39,041 | $97 |
| Return visit (30+ min) | 206 | $23,840 | $72 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 21 | $8,894 | $151 |
| Diagnostic exam of voice box using a flexible endoscope | 140 | $8,083 | $50 |
| Short return visit (20+ min) | 123 | $7,193 | $49 |
| Diagnostic exam of nasal passages using an endoscope | 81 | $4,706 | $45 |
| Removal of impacted ear wax | 121 | $3,607 | $21 |
| Short return visit | 106 | $3,172 | $25 |
| Preparation of skin graft site of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 100.0 sq cm or 1% body area for infants and children, or less | 13 | $2,944 | $210 |
| New patient visit (30+ min) | 44 | $2,503 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,383 | $159 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,514 | $108 |
| Incision, aspiration, and/or inflation of eardrum | 12 | $1,185 | $99 |
| Simple control of nose bleed | 18 | $916 | $38 |
| Exam of ear using a microscope | 31 | $298 | $7 |
2021: 11 services
| New patient visit (45+ min) | 481 | $46,701 | $97 |
| Return visit (30+ min) | 204 | $21,768 | $77 |
| Diagnostic exam of voice box using a flexible endoscope | 171 | $9,504 | $50 |
| Diagnostic exam of nasal passages using an endoscope | 89 | $7,798 | $46 |
| Short return visit (20+ min) | 99 | $6,334 | $48 |
| Short return visit | 120 | $3,985 | $28 |
| Removal of impacted ear wax | 81 | $2,179 | $24 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,125 | $152 |
| Simple control of nose bleed | 22 | $939 | $39 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 13 | $378 | $27 |
| Exam of ear using a microscope | 37 | $331 | $7 |
2020: 8 services
| New patient visit (45+ min) | 119 | $12,415 | $104 |
| Short return visit (20+ min) | 45 | $3,051 | $42 |
| Return visit (30+ min) | 33 | $2,810 | $65 |
| Diagnostic exam of voice box using a flexible endoscope | 38 | $2,329 | $53 |
| Diagnostic exam of nasal passages using an endoscope | 15 | $1,114 | $46 |
| Comprehensive hearing and speech recognition test | 36 | $975 | $27 |
| Removal of impacted ear wax | 20 | $648 | $27 |
| Test to assess middle ear function | 34 | $307 | $9 |
Medicaid work
$10,554 in 2024
Medicaid paid $10,554 for 220 billed services this clinician did in 2024, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OFF/OP CNSLTJ NEW/EST MOD 40 | 79 | $6,375 |
| Return visit (30+ min) | 141 | $4,180 |
| 2024 | 220 | 2 | 26 | $10,554 |
| 2023 | 410 | 5 | 26 | $17,400 |
| 2022 | 819 | 14 | 35 | $40,944 |
| 2021 | 645 | 8 | 33 | $36,951 |
| 2020 | 175 | 5 | 28 | $13,339 |
See the largest Medicaid services in earlier years
2023
| OFF/OP CNSLTJ NEW/EST MOD 40 | 146 | $10,649 |
| Return visit (30+ min) | 160 | $5,839 |
| Service | 78 | $872 |
| Injection, dexamethasone sodium phosphate, 1 mg | 13 | $20 |
| Injection, propofol, 10 mg | 13 | $20 |
2022
| OFF/OP CNSLTJ NEW/EST MOD 40 | 265 | $19,751 |
| Return visit (30+ min) | 211 | $11,818 |
| Diagnostic flexible fiberoptic laryngoscopy | 55 | $3,964 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 27 | $1,310 |
| Short return visit | 30 | $984 |
| Service | 70 | $800 |
| Short return visit (20+ min) | 13 | $781 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 12 | $637 |
| Service | 12 | $339 |
| Unclassified drugs | 16 | $317 |
| Ringers lactate infusion, up to 1000 cc | 15 | $115 |
| Injection, dexamethasone sodium phosphate, 1 mg | 13 | $70 |
2021
| OFF/OP CNSLTJ NEW/EST MOD 40 | 288 | $21,715 |
| Return visit (30+ min) | 63 | $5,347 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 54 | $5,146 |
| Diagnostic flexible fiberoptic laryngoscopy | 26 | $1,986 |
| Short return visit (20+ min) | 30 | $1,641 |
| Short return visit | 15 | $588 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 12 | $529 |
| Hospital outpatient clinic visit for assessment and management of a patient | 157 | $0 |
2020
| OFF/OP CNSLTJ NEW/EST MOD 40 | 106 | $7,529 |
| Service | 15 | $3,146 |
| Short return visit (20+ min) | 30 | $1,932 |
| Comprehensive audiometry threshold evaluation and speech recognition | 12 | $373 |
| Service | 12 | $359 |
Drugs they prescribed that Part D paid
$6,974
Pharmacies billed $6,974 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 6% of their Part D prescriptions (22 of 390) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.
385 generic and fewer than 11 brand-name prescriptions · $6,974 in drug cost · 95 antibiotic prescriptions to 66 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Azelastine | 31 | $1,013 | $33 |
| Ipratropium | 36 | $801 | $22 |
| Omeprazole | 32 | $521 | $16 |
| Fluticasone Propionate | 48 | $427 | $9 |
| Mupirocin | 59 | $338 | $6 |
See all 10 drugs
| Azelastine | 31 | $1,013 | $33 |
| Ipratropium | 36 | $801 | $22 |
| Omeprazole | 32 | $521 | $16 |
| Fluticasone Propionate | 48 | $427 | $9 |
| Mupirocin | 59 | $338 | $6 |
| Levocetirizine Dihydrochloride | 14 | $316 | $23 |
| Doxycycline Monohydrate | 24 | $251 | $10 |
| Amoxicillin-Clavulanate Potass | 19 | $176 | $9 |
| Cephalexin | 33 | $94 | $3 |
| Oxycodone | 21 | $63 | $3 |
Year by year
| 2024 | 390 | 152 | 6% (22) | None | $6,974 |
| 2023 | 414 | 161 | 5% (19) | 3% | $10,777 |
| 2022 | 543 | 224 | 7% (38) | 2% | $13,683 |
| 2021 | 512 | 205 | 5% (24) | 2% | $13,651 |
| 2020 | 97 | 44 | None | None | $2,323 |
| 2019 | 21 | 15 | None | None | $206 |
| 2018 | 72 | 44 | 29% (21) | None | $1,274 |
| 2017 | 21 | 14 | None | None | $1,485 |
| 2016 | 99 | 62 | 34% (34) | 12% | $4,208 |
| 2015 | 78 | 45 | 18% (14) | None | $2,424 |
| 2014 | 15 | None | None | None | $245 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Azelastine | 38 | $1,040 | $27 |
| Mupirocin | 82 | $1,036 | $13 |
| Ipratropium | 27 | $1,026 | $38 |
| Omeprazole | 39 | $801 | $21 |
| Fluticasone Propionate | 46 | $649 | $14 |
| Amoxicillin-Clavulanate Potass | 19 | $398 | $21 |
| Cephalexin | 31 | $263 | $8 |
| Doxycycline Monohydrate | 14 | $197 | $14 |
| Oxycodone | 14 | $65 | $5 |
2022: 15 drugs
| Ofloxacin | 15 | $1,437 | $96 |
| Azelastine | 21 | $923 | $44 |
| Neomycin-Polymyxin-Hydrocort | 15 | $904 | $60 |
| Dexamethasone Sodium Phosphate | 17 | $801 | $47 |
| Amoxicillin-Clavulanate Potass | 39 | $786 | $20 |
| Omeprazole | 33 | $718 | $22 |
| Mupirocin | 66 | $659 | $10 |
| Fluticasone Propionate | 55 | $645 | $12 |
| Levocetirizine Dihydrochloride | 15 | $644 | $43 |
| Doxycycline Monohydrate | 19 | $557 | $29 |
| Cephalexin | 55 | $412 | $7 |
| Azithromycin | 35 | $226 | $6 |
| Ipratropium | 13 | $197 | $15 |
| Oxycodone | 24 | $128 | $5 |
| Methylprednisolone | 11 | $103 | $9 |
2021: 14 drugs
| Ciprofloxacin-Dexamethasone | 15 | $2,508 | $167 |
| Fluticasone Propionate | 117 | $1,579 | $13 |
| Neomycin-Polymyxin-Hydrocort | 18 | $1,191 | $66 |
| Omeprazole | 48 | $1,119 | $23 |
| Azelastine | 16 | $815 | $51 |
| Ipratropium | 21 | $791 | $38 |
| Clotrimazole | 15 | $601 | $40 |
| Amoxicillin-Clavulanate Potass | 40 | $519 | $13 |
| Dexamethasone Sodium Phosphate | 12 | $412 | $34 |
| Doxycycline Monohydrate | 16 | $373 | $23 |
| Mupirocin | 44 | $313 | $7 |
| Cephalexin | 33 | $259 | $8 |
| Prednisone | 16 | $165 | $10 |
| Oxycodone | 20 | $59 | $3 |
2020: 1 drug
| Fluticasone Propionate | 28 | $446 | $16 |
2018: 2 drugs
| Oxycodone | 18 | $263 | $15 |
| Cephalexin | 15 | $84 | $6 |
2016: 2 drugs
| Oxycodone | 25 | $564 | $23 |
| Cephalexin | 12 | $68 | $6 |
Money from drug and device companies
$149 in 2025
| 2025 | 1 | 2 | None | $149 |
| 2024 | 2 | 5 | None | $177 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Botox | $149 | 2 payments
|
See all 2 published payments
| Abbvie | Meals · 2025-12-08 | Botox | $130 |
| Abbvie | Meals · 2025-08-04 | Botox | $19 |
See earlier years (2024)
2024: $177
| Abbvie | Botox | $110 | 4 payments
|
| Galderma Laboratories L.P. | None | $67 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1356769699
- Licence
- CA A161622California A161622: Current · expires 2027-03-31
- Trained
- George Washington University School of Medicine, 2014
- Group
- Enloe Medical Center
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2082S0099X (2082S0099X); Federal specialty code 207YX0905X (207YX0905X)
- Mailing address
- 1691 El Camino Real Ste 400, Palo Alto, CA, 94306
- NPI first listed
- 2014-04-03
- NPI last updated
- 2026-08-16
- NPI record certified
- 2026-08-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 830 Harrison Ave, Boston, MA, 02118 · 135 Mission Ranch Blvd, Chico, CA, 95926 · 171 Main Street, Suite 404, Los Altos, CA, 94022